tradingkey.logo

India's Shilpa Medicare jumps after FDA clears Bengaluru unit

ReutersJul 16, 2025 5:51 AM

Shares of Shilpa Medicare SHME.NS climb 4.5% to 932.6 rupees; set for best day in about 2 months

Pharma co says U.S. FDA issues voluntary action indicated (VAI) classification for a Bengaluru facility

VAI classification implies that the facility will not face any regulatory action

YTD, stock up 14% so far

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI